XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.25.2

Intangible Assets (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Intangible Assets [Abstract] |
Schedule of Intangible Assets | Intangible assets consisted of the following:
Intangible Assets |  | June 30, 2025 |  |  | December 31, 2024 |
Licenses |  |  |  |  |  |
Non-Exclusive License Agreement |  | $ | 179,821 |  |  | $ | 179,821 |
Various generic drugs |  |  | 736,983 |  |  |  | 736,983 |
Four generic drugs (Encore) |  |  | 1,308,270 |  |  |  | 1,308,270 |
Needleless Syringe License |  |  | 26,060 |  |  |  | 26,060 |
Patents |  |  | 48,420 |  |  |  | 48,420 |
Total intangible assets |  | $ | 2,299,554 |  |  | $ | 2,299,554 |

X
- References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsNetAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration